Omitting systematic biopsy in men with elevated prostate-specific antigen (PSA) levels and negative MRI results, and performing only targeted biopsy of MRI-positive lesions, eliminated more than half ...
New biomarker technology shows promising results for predicting the prognosis of patients with prostate cancer after radical prostatectomy. According to new research published in Cancers, the use of ...
Omitting biopsy in patients with a negative prostate MRI more than halves the diagnoses of clinically insignificant prostate cancer. Detection of clinically insignificant ISUP grade group 1 prostate ...
Reference Mattlet A, Limani K, Alexandre P, Hawaux E, et al. External validation of biochemical recurrence definition to predict oncologic outcomes following focal therapy for localized prostate ...
The diagnostics advisory committee considered evidence on MRI fusion biopsy systems using Artemis, Biojet, BiopSee, bkFusion, Fusion Bx 2.0, FusionVu, iSR'obot Mona Lisa, KOELIS Trinity and UroNav ...
Employing MRI-targeted biopsy instead of systematic biopsy reduces overdiagnosis of low-grade prostate cancer by more than half, although diagnoses may be delayed among a small minority of patients ...
LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for failure-free survival, according to a randomized trial reported here. After 3 years ...
The prognosis of grade group 1 prostate cancer varies widely, with high-risk features increasing the possibility of adverse pathology, biochemical recurrence, and in some cases, death. Gleason grade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback